24 May 2013
Keywords: beaufour, gets, eu, ok, nutropin, aq, france
Article | 24 March 2003
France's Beaufour Ipsen has received approval from the EuropeanMedicines Evaluation Agency for marketing the recombinant growth hormone
Nutropin AQ (somatropin [ ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
24 March 2003
17 March 2003
© 2013 thepharmaletter.com